These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19696702)

  • 1. Photodynamic therapy with verteporfin for avascular serous pigment epithelial detachment in elderly Koreans.
    Kim KS; Lee WK
    Retina; 2010 Jan; 30(1):93-9. PubMed ID: 19696702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced-fluence photodynamic therapy for subfoveal serous pigment epithelial detachment with choroidal vascular hyperpermeability.
    Goto S; Gomi F; Ueno C; Nishida K
    Am J Ophthalmol; 2012 Nov; 154(5):865-871.e1. PubMed ID: 22840480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated pigment epithelium detachment: evidence for relation to central serous chorioretinopathy and effect of photodynamic therapy.
    Arif F; Pryds A; Larsen M
    Acta Ophthalmol; 2018 Dec; 96(8):821-827. PubMed ID: 30246489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study.
    Lai TY; Chan WM; Li H; Lai RY; Liu DT; Lam DS
    Br J Ophthalmol; 2006 Jul; 90(7):869-74. PubMed ID: 16597666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment.
    Saito M; Iida T; Nagayama D
    Br J Ophthalmol; 2008 Dec; 92(12):1642-7. PubMed ID: 18782798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with verteporfin for retinal angiomatous proliferation.
    Boscia F; Parodi MB; Furino C; Reibaldi M; Sborgia C
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1224-32. PubMed ID: 16525824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.
    Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M
    Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.
    Introini U; Torres Gimeno A; Scotti F; Setaccioli M; Giatsidis S; Bandello F
    Graefes Arch Clin Exp Ophthalmol; 2012 Sep; 250(9):1283-92. PubMed ID: 22350060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration.
    Pece A; Isola V; Vadalà M; Calori G
    Retina; 2007 Mar; 27(3):342-8. PubMed ID: 17460590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
    Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
    Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
    Axer-Siegel R; Ehrlich R; Rosenblatt I; Kramer M; Priel E; Yassur Y; Weinberger D
    Arch Ophthalmol; 2004 Apr; 122(4):453-9. PubMed ID: 15078661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
    Smretschnig E; Ansari-Shahrezaei S; Hagen S; Glittenberg C; Krebs I; Binder S
    Retina; 2013 Feb; 33(2):316-23. PubMed ID: 23314238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy.
    Kim SW; Oh J; Oh IK; Huh K
    Ophthalmic Surg Lasers Imaging; 2009; 40(3):300-3. PubMed ID: 19485297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHOTODYNAMIC THERAPY FOR SYMPTOMATIC SUBFOVEAL RETINAL PIGMENT EPITHELIAL DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: Outcomes and Prognostic Factors.
    Hwang S; Kang SW; Kim SJ; Jang JW; Kim KT
    Retina; 2019 Jun; 39(6):1117-1124. PubMed ID: 29517581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy treatment for eyes with drusenoid pigment epithelium detachment.
    Lee NY; Kim KS
    Korean J Ophthalmol; 2008 Sep; 22(3):194-6. PubMed ID: 18784450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy.
    Lee PY; Kim KS; Lee WK
    Jpn J Ophthalmol; 2009 Jan; 53(1):52-56. PubMed ID: 19184311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment.
    Boscia F; Furino C; Sborgia L; Reibaldi M; Sborgia C
    Am J Ophthalmol; 2004 Dec; 138(6):1077-9. PubMed ID: 15629318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Photodynamic therapy for chronic central serous chorioretinopathy and diffuse retinal epitheliopathy].
    Cornut PL; Quaranta-El Maftouhi M; Mauget-Faÿsse M
    J Fr Ophtalmol; 2012 Feb; 35(2):82-7. PubMed ID: 21889817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICG angiography-guided photodynamic therapy for large pigment epithelial detachments in age-related macular degeneration.
    Wygnanski-Jaffe T; Desatnik H; Alhalel A; Goldstein M; Lowenstein A; Zolf R; Moisseiev J
    Ophthalmic Surg Lasers Imaging; 2006; 37(5):358-63. PubMed ID: 17017194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of half-fluence photodynamic therapy depending on the degree of choroidal hyperpermeability in chronic central serous chorioretinopathy.
    Lim SH; Chang W; Sagong M
    Eye (Lond); 2013 Mar; 27(3):353-62. PubMed ID: 23449515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.